Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human GYS1 Protein, N-His

Catalog #:   YHD01601 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P13807
Protein length: Asn26-Arg272
Overview

Catalog No.

YHD01601

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn26-Arg272

Predicted molecular weight

30.09 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P13807

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Glycogen [starch] synthase, muscle, GYS1, GYS

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human GYS1 Protein
References

Expanding the clinical phenotype and understanding the biochemical consequences of Muscle Glycogen Synthase Deficiency (GSD0B)., PMID:40398079

Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning., PMID:40366616

FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma., PMID:40316306

The metabolic enzyme GYS1 condenses with NONO/p54nrb in the nucleus and spatiotemporally regulates glycogenesis and myogenic differentiation., PMID:40200092

LC-HRMS profiling of Dendrobium huoshanense aqueous extract and its therapeutic effects on nonalcoholic fatty liver disease in mice through the TLR2-NF-κB and AMPK-SREBP1-SIRT1 signaling pathways., PMID:40107184

The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas., PMID:40090159

Unveiling the crucial role of glycosylation modification in lung adenocarcinoma metastasis through artificial neural network-based spatial multi-omics single-cell analysis and Mendelian randomization., PMID:39948531

Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative disease., PMID:39806098

Identifying disulfidptosis-related biomarkers in epilepsy based on integrated bioinformatics and experimental analyses., PMID:39805370

The Proteomic Landscape of the Coronary Accessible Heart Cell Surfaceome., PMID:39790063

A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease., PMID:39604266

Metformin Improves the Function of Abdominal Aortic Aneurysm Patient-Derived Aortic Smooth Muscle Cells., PMID:39321955

Overexpression of SLC2A1, ALDOC, and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids., PMID:39295558

Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms., PMID:39206541

Small molecule inhibition of glycogen synthase I reduces muscle glycogen content and improves biomarkers in a mouse model of Pompe disease., PMID:39171753

Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation., PMID:39061076

Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL)., PMID:39000261

PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells., PMID:38871968

NMT2 alleviates depression-like behavior in a rat model of chronic unpredictable stress: An integrated proteomic and phosphoproteomic analysis., PMID:38852542

Glycogen synthesis is required for adaptive thermogenesis in beige adipose tissue and affects diet-induced obesity., PMID:38568151

Novel 4th-generation phytase improves broiler growth performance and reduces woody breast severity through modulation of muscle glucose uptake and metabolism., PMID:38559573

[Preliminary study on the effect of Echinococcus multilocaris on phenotypic transformations of glucose metabolism and polarization types in macrophages]., PMID:38413020

Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma., PMID:37927242

Inhibition of mitochondrial fission activates glycogen synthesis to support cell survival in colon cancer., PMID:37816729

Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model., PMID:37700152

Molecular insights into the lipid-carbohydrates metabolism switch under the endurance effort in Arabian horses., PMID:37565649

MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway., PMID:37404479

Glycogen-fuelled metabolism supports rapid mucosal-associated invariant T cell responses., PMID:37307453

Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review., PMID:37239976

Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)., PMID:37185710

Integrative metabolomic and transcriptomic analysis reveals difference in glucose and lipid metabolism in the longissimus muscle of Luchuan and Duroc pigs., PMID:37091786

Identification of novel immune subtypes and potential hub genes of patients with psoriasis., PMID:36890558

Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism., PMID:36111639

Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation., PMID:35976051

Plasma Exosomal miRNAs Associated With Metabolism as Early Predictor of Gestational Diabetes Mellitus., PMID:35926094

The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex., PMID:35793618

Comparison of porcine milk microRNA expression in milk exosomes versus whole swine milk and prediction of target genes., PMID:35136833

DNA demethylase ALKBH1 promotes adipogenic differentiation via regulation of HIF-1 signaling., PMID:34922943

p38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1., PMID:34758018

miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells., PMID:34113143

Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models., PMID:33830476

Quantitative Proteomics Analysis for the Identification of Differential Protein Expression in Calf Muscles between Young and Old SD Rats Using Mass Spectrometry., PMID:33778255

The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas., PMID:33727611

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice., PMID:33277363

Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus., PMID:33191074

Chorionic somatomammotropin RNA interference alters fetal liver glucose utilization., PMID:33108344

Expression of Myosin Heavy Chain and Some Energy Metabolism-Related Genes in the Longissimus Dorsi Muscle of Krškopolje Pigs: Effect of the Production System., PMID:33062658

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease., PMID:33034425

GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma., PMID:32802186

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human GYS1 Protein, N-His [YHD01601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only